zhen-zhong wang
Jiangsu Kanion Pharmaceutical Co., Ltd.
Lianyungang, China
Review Editor
Cardiovascular and Hematologic Drugs
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
karen c. weber
Federal University of Paraíba
João Pessoa, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
charles h williams
Michigan State University
East Lansing, United States
Review Editor
Cardiovascular and Hematologic Drugs
kelin xia
Nanyang Technological University
Singapore, Singapore
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
shunbin xiong
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Anti-Cancer Drugs
huji xu
Tsinghua University
Beijing, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
tao xu
University of Florida
Gainesville, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
xiaowei xu
University of Arkansas at Little Rock
Little Rock, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
ziyi xu
Boston University
Boston, United States
Review Editor
Anti-Infective Agents
fengtian xue
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
jingyi xue
King's College London
London, United Kingdom
Review Editor
Technologies and Strategies to Enable Drug Discovery
yan-yan yan
Shanxi Datong University
Datong, China
Review Editor
Anti-Cancer Drugs
chao yang
Exo Therapeutics
Cambridge, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
fengyuan yang
Chongqing University
Chongqing, China
Review Editor
Anti-Infective Agents
zhaogang yang
Jilin University
Changchun, China
Review Editor
Anti-inflammatory and Immunomodulating Agents
xiao jun yao
Macau University of Science and Technology
Taipa, China
Review Editor
Anti-Cancer Drugs